Stem cell-derived endochondral cartilage stimulates bone healing by tissue transformation

Journal of Bone and Mineral Research

Volumn 29, Issue 5, 2014, Pages 1269-1282

  Bahney, Chelsea S ^a,b   Hu, Diane P ^a   Taylor, Aaron J ^a   Ferro, Federico ^a   Britz, Hayley M ^c   Hallgrimsson, Benedikt ^d   Johnstone, Brian ^d   Miclau, Theodore ^a   Marcucio, Ralph S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

bioengineering; cartilage biology; chondrocytes; injury fracture healing; molecular pathways; remodeling; therapeutics

Indexed keywords

BONE MORPHOGENETIC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE NECROSIS; BONE REGENERATION; BONE TRANSPLANTATION; CARTILAGE CELL; CARTILAGE GRAFT; CHONDROGENESIS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; FRACTURE HEALING; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; TIBIA; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CARTILAGE; CYTOLOGY; HUMAN; METABOLISM; PROCEDURES; STEM CELL;

ANIMALS; BONE REGENERATION; CARTILAGE; HUMANS; MALE; MICE; STEM CELLS; TIBIA; TISSUE ENGINEERING;

EID: 84896707848     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2148     Document Type: Article

References (70)

1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2224-60.
2. Agency for Healthcare Research and Quality. Available Hospital Based Emergency Care: At the Breaking Point. In Ch 8. The National Acadamies Press 2007. ISBN 0309101735, 9780309101738.
3. American Academy of Orthopaedic Surgeons. The burden of musculoskeletal diseases in the United States. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2008.
4. Nguyen LH, Annabi N, Nikkhah M, et al. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev. 2012; 18 (5): 363-82.
5. Brigman BE, Hornicek FJ, Gebhardt MC, Mankin HJ,. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res. 2004; (421): 232-9.
6. Kronenberg HM,. Developmental regulation of the growth plate. Nature. 2003; 423 (6937): 332-6.
7. Colnot C, Lu C, Hu D, Helms JA,. Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol. 2004; 269 (1): 55-69.
8. Little DG, Ramachandran M, Schindeler A,. The anabolic and catabolic responses in bone repair. J Bone Joint Surg Br. 2007; 89 (4): 425-33.
9. Tiyapatanaputi P, Rubery PT, Carmouche J, Schwarz EM, O'Keefe RJ, Zhang X,. A novel murine segmental femoral graft model. J Orthop Res. 2004; 22 (6): 1254-60.
10. Lee FY, Hazan EJ, Gebhardt MC, Mankin HJ,. Experimental model for allograft incorporation and allograft fracture repair. J Orthop Res. 2000; 18 (2): 303-6.
11. Ito H, Koefoed M, Tiyapatanaputi P, et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med. 2005; 11 (3): 291-7.
12. Yu YY, Bahney C, Hu D, Marcucio RS, Miclau T 3rd., Creating rigidly stabilized fractures for assessing intramembranous ossification, distraction osteogenesis, or healing of critical sized defects. J Vis Exper. 2012; (62).
13. Thompson Z, Miclau T, Hu D, Helms JA,. A model for intramembranous ossification during fracture healing. J Orthop Res. 2002; 20 (5): 1091-8.
14. Hu D, Marcucio RS,. A SHH-responsive signaling center in the forebrain regulates craniofacial morphogenesis via the facial ectoderm. Development. 2009; 136 (1): 107-16.
15. Rumballe B, Georgas K, Little MH,. High-throughput paraffin section in situ hybridization and dual immunohistochemistry on mouse tissues. CSH Protoc. 2008; 2008: pdb prot5030.
16. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU,. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238 (1): 265-72.
17. Buxton AN, Bahney CS, Yoo J, Johnstone B,. Temporal exposure to chondrogenic factors modulates human mesenchymal stem cell chondrogenesis in hydrogels. Tissue Eng Part A. 2010; 16 (5): 1693-702.
18. Buxton AN, Zhu J, Marchant R, West JL, Yoo JU, Johnstone B,. Design and characterization of poly(ethylene glycol) photopolymerizable semi-interpenetrating networks for chondrogenesis of human mesenchymal stem cells. Tissue Eng. 2007; 13 (10): 2549-60.
19. Bahney CS, Hsu CW, Yoo JU, West JL, Johnstone B,. A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB J. 2011; 25 (5): 1486-96.
20. Bahney CS, Hsu CW, Bottlang M, West JL, Johnstone B,. Visible light photoinitiation of mesenchymal stem cell-laden bioresponsive hydrogels. Eur Cells Mater. 2011; 22: 43-55.
21. Yoo JU, Barthel TS, Nishimura K, et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998; 80 (12): 1745-57.
22. Burchardt H, Enneking WF,. Transplantation of bone. Surg Clin N Am. 1978; 58 (2): 403-27.
23. De Long WG Jr, Einhorn TA, Koval K, et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am. 2007; 89 (3): 649-58.
24. Benevenia J, Zimmerman M, Keating J, Cyran F, Blacksin M, Parsons JR,. Mechanical environment affects allograft incorporation. J Biomed Mater Res. 2000; 53 (1): 67-72.
25. Enneking WF, Campanacci DA,. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am. 2001; 83-A (7): 971-86.
26. Wheeler DL, Enneking WF,. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res. 2005; (435): 36-42.
27. Hiltunen MO, Ruuskanen M, Huuskonen J, et al. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J. 2003; 17 (9): 1147-9.
28. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH,. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res. 2006; 21 (5): 735-44.
29. Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ,. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials. 2006; 27 (17): 3249-55.
30. Zisch AH, Lutolf MP, Ehrbar M, et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 2003; 17 (15): 2260-2.
31. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N,. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999; 5 (6): 623-8.
32. Behonick DJ, Xing Z, Lieu S, et al. Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration. PloS One. 2007; 2 (11): e1150.
33. Yu YY, Lieu S, Lu C, Miclau T, Marcucio RS, Colnot C,. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair. Bone. 2010; 46 (3): 841-51.
34. Gerstenfeld LC, Cruceta J, Shea CM, Sampath K, Barnes GL, Einhorn TA,. Chondrocytes provide morphogenic signals that selectively induce osteogenic differentiation of mesenchymal stem cells. J Bone Miner Res. 2002; 17 (2): 221-30.
35. Schipani E,. Hypoxia and HIF-1alpha in chondrogenesis. Ann NY Acad Sci. 2006; 1068: 66-73.
36. Lu C, Miclau T, Hu D, Marcucio RS,. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res. 2007; 25 (1): 51-61.
37. Dickson KF, Katzman S, Paiement G,. The importance of the blood supply in the healing of tibial fractures. Contemp Orthop. 1995; 30 (6): 489-93.
38. Muraglia A, Cancedda R, Quarto R,. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci. 2000; 113 (Pt 7): 1161-6.
39. Oliveira SM, Amaral IF, Barbosa MA, Teixeira CC,. Engineering endochondral bone: in vitro studies. Tissue Eng Part A. 2009; 15 (3): 625-34.
40. Riminucci M, Bradbeer JN, Corsi A, et al. Vis-a-vis cells and the priming of bone formation. J Bone Miner Res. 1998; 13 (12): 1852-61.
41. Jukes JM, Both SK, Leusink A, Sterk LM, van Blitterswijk CA, de Boer J,. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci USA. 2008; 105 (19): 6840-5.
42. Dickhut A, Pelttari K, Janicki P, et al. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol. 2009; 219 (1): 219-26.
43. Pelttari K, Winter A, Steck E, et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 2006; 54 (10): 3254-66.
44. Scotti C, Tonnarelli B, Papadimitropoulos A, et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci USA. 2010; 107 (16): 7251-6.
45. Oliveira SM, Mijares DQ, Turner G, Amaral IF, Barbosa MA, Teixeira CC,. Engineering endochondral bone: in vivo studies. Tissue Eng Part A. 2009; 15 (3): 635-43.
46. Vacanti CA, Kim W, Upton J, Mooney D, Vacanti JP,. The efficacy of periosteal cells compared to chondrocytes in the tissue engineered repair of bone defects. Tissue Eng. 1995; 1 (3): 301-8.
47. Scotti C, Piccinini E, Takizawa H, et al. Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci USA. 2013; 110 (10): 3997-4002.
48. Huang JI, Durbhakula MM, Angele P, Johnstone B, Yoo JU,. Lunate arthroplasty with autologous mesenchymal stem cells in a rabbit model. J Bone Joint Surg Am. 2006; 88 (4): 744-52.
49. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007; 131 (2): 324-36.
50. Roach HI,. New aspects of endochondral ossification in the chick: chondrocyte apoptosis, bone formation by former chondrocytes, and acid phosphatase activity in the endochondral bone matrix. J Bone Miner Res. 1997; 12 (5): 795-805.
51. Hall BK,. Dedifferentiation provides progenitor cells for jaws and long bones. In: Bones and cartilage: developmental and evolutionary skeletal biology. 1st ed. San Diego: Academic Press; 2005. p. 166-82.
52. Yoshioka C, Yagi T,. Electron microscopic observations on the fate of hypertrophic chondrocytes in condylar cartilage of rat mandible. J Craniofac Genet Dev Biol. 1988; 8 (3): 253-64.
53. Kuhlman RE, McNamee MJ,. The biochemical importance of the hypertrophic cartilage cell area to enchondral bone formation. J Bone Joint Surg Am. 1970; 52 (5): 1025-32.
54. Holtrop ME,. The ultrastructure of the epiphyseal plate. II. The hypertrophic chondrocyte. Calcif Tissue Res. 1972; 9 (2): 140-51.
55. Maes C, Kobayashi T, Selig MK, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell. 2010; 19 (2): 329-44.
56. Yasui N, Sato M, Ochi T, et al. Three modes of ossification during distraction osteogenesis in the rat. J Bone Joint Surg Br. 1997; 79 (5): 824-30.
57. Song L, Tuan RS,. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J. 2004; 18 (9): 980-2.
58. Roach HI,. Trans-differentiation of hypertrophic chondrocytes into cells capable of producing a mineralized bone matrix. Bone Miner. 1992; 19 (1): 1-20.
59. Scammell BE, Roach HI,. A new role for the chondrocyte in fracture repair: endochondral ossification includes direct bone formation by former chondrocytes. J Bone Miner Res. 1996; 11 (6): 737-45.
60. Galotto M, Campanile G, Robino G, Cancedda FD, Bianco P, Cancedda R,. Hypertrophic chondrocytes undergo further differentiation to osteoblast-like cells and participate in the initial bone formation in developing chick embryo. J Bone Miner Res. 1994; 9 (8): 1239-49.
61. Pritchard JJ, Ruzicka AJ,. Comparison of fracture repair in the frog, lizard and rat. J Anat. 1950; 84 (3): 236-61.
62. Kawakami T, Kawai T, Kimura A, et al. Characteristics of bone morphogenetic protein-induced chondroid bone: histochemical, immunohistochemical and in situ hybridization examinations. J Int Med Res. 2001; 29 (6): 480-7.
63. Aigner T, Loos S, Muller S, Sandell LJ, Unni KK, Kirchner T,. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas. Am J Pathol. 2000; 156 (4): 1327-35.
64. Hughes SS, Hicks DG, O'Keefe RJ, et al. Shared phenotypic expression of osteoblasts and chondrocytes in fracture callus. J Bone Miner Res. 1995; 10 (4): 533-44.
65. Gerstenfeld LC, Shapiro FD,. Expression of bone-specific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. J Cell Biochem. 1996; 62 (1): 1-9.
66. Lian JB, McKee MD, Todd AM, Gerstenfeld LC,. Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem. 1993; 52 (2): 206-19.
67. Stafford HJ, Roberts MT, Oni OO, Hay J, Gregg P,. Localisation of bone-forming cells during fracture healing by osteocalcin immunocytochemistry: an experimental study of the rabbit tibia. J Orthop Res. 1994; 12 (1): 29-39.
68. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA,. Altered fracture repair in the absence of MMP9. Development. 2003; 130 (17): 4123-33.
69. Matsubara H, Hogan DE, Morgan EF, Mortlock DP, Einhorn TA, Gerstenfeld LC,. Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis. Bone. 2012; 51 (1): 168-80.
70. Kang Y, Kim S, Fahrenholtz M, Khademhosseini A, Yang Y,. Osteogenic and angiogenic potentials of monocultured and co-cultured human-bone-marrow-derived mesenchymal stem cells and human-umbilical-vein endothelial cells on three-dimensional porous beta-tricalcium phosphate scaffold. Acta Biomater. 2013; 9 (1): 4906-15.